The estimated Net Worth of Louis A Bianco is at least $10.5 Milión dollars as of 19 November 2015. Louis Bianco owns over 15,000 units of CTI BioPharma Corp stock worth over $8,238,694 and over the last 21 years Louis sold CTIC stock worth over $2,280,549.
Louis has made over 38 trades of the CTI BioPharma Corp stock since 2004, according to the Form 4 filled with the SEC. Most recently Louis sold 15,000 units of CTIC stock worth $16,950 on 19 November 2015.
The largest trade Louis's ever made was selling 250,000 units of CTI BioPharma Corp stock on 9 December 2010 worth over $92,500. On average, Louis trades about 21,070 units every 59 days since 2003. As of 19 November 2015 Louis still owns at least 906,347 units of CTI BioPharma Corp stock.
You can see the complete history of Louis Bianco stock trades at the bottom of the page.
Louis's mailing address filed with the SEC is 501 ELLIOT AVENUE WEST, SUITE 400, SEATTLE, WA, 98119.
Over the last 21 years, insiders at CTI BioPharma Corp have traded over $80,110,449 worth of CTI BioPharma Corp stock and bought 9,566,060 units worth $25,487,533 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog... a Advisors Llc Orbi Med Capit.... On average, CTI BioPharma Corp executives and independent directors trade stock every 26 days with the average trade being worth of $1,223,687. The most recent stock trade was executed by Adam R Craig on 24 January 2023, trading 85,317 units of CTIC stock currently worth $71,666.
cti was founded on the belief that a coalition between unique scientific technology and its strong desire to “do right” by the patient could help us achieve our mission to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. we strive to do business better than other biopharmaceutical companies. better means a more collaborative, well-trained team environment willing to institute novel approaches to scientific discovery and business opportunities. a willingness to push the limits to achieve challenging goals is the essential attribute that sets cti employees apart.
CTI BioPharma Corp executives and other stock owners filed with the SEC include: